User profiles for Jennifer X. Ji

Jennifer X. Ji

University of British Columbia
Verified email at alumni.ubc.ca
Cited by 558

SWI/SNF complex mutations in gynecologic cancers: molecular mechanisms and models

Y Wang, L Hoang, JX Ji… - Annual Review of …, 2020 - annualreviews.org
The SWI/SNF (mating type SWItch/Sucrose NonFermentable) chromatin remodeling
complexes interact with histones and transcription factors to modulate chromatin structure and …

Clear cell carcinomas of the ovary and kidney: clarity through genomics

JX Ji, YK Wang, DR Cochrane… - The Journal of …, 2018 - Wiley Online Library
Clear cell ovarian carcinoma (CCOC) and clear cell renal cell carcinoma (ccRCC) both
feature clear cytoplasm, owing to the accumulation of cytoplasmic glycogen. Genomic studies …

Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous …

YA Liu, JX Ji, N Almadani, RI Crawford… - …, 2021 - Wiley Online Library
Aims Differentiated vulvar intraepithelial neoplasia (dVIN), the precursor lesion to human
papillomavirus‐independent vulvar squamous cell carcinoma (VSCC), can be difficult to …

The proteome of clear cell ovarian carcinoma

JX Ji, DR Cochrane, GL Negri… - The Journal of …, 2022 - Wiley Online Library
Clear cell ovarian carcinoma (CCOC) is the second most common subtype of epithelial
ovarian carcinoma. Late‐stage CCOC is not responsive to gold‐standard chemotherapy and …

Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase–deficient ovarian cancer, including small-cell carcinoma of the ovary …

JX Ji, DR Cochrane, B Tessier-Cloutier, SY Chen… - Clinical Cancer …, 2020 - AACR
Purpose: Many rare ovarian cancer subtypes, such as small-cell carcinoma of the ovary,
hypercalcemic type (SCCOHT), have poor prognosis due to their aggressive nature and …

[HTML][HTML] The Canadian clinician-scientist training program must be reinstated

…, JW Squair, MA Skinnider, JX Ji - The Journal of Clinical …, 2015 - Am Soc Clin Investig
Clinical investigators within the Canadian and international communities were shocked when
the Canadian Institutes of Health Research (CIHR) announced that their funding for the MD…

Napsin-A and AMACR are superior to HNF-1β in distinguishing between mesonephric carcinomas and clear cell carcinomas of the gynecologic tract

J Pors, S Segura, A Cheng, JX Ji… - Applied …, 2020 - journals.lww.com
Mesonephric carcinoma is a rare gynecologic neoplasm commonly mistaken for clear cell
carcinoma, because of their overlapping morphologic features. Both tumors are negative for …

Characteristics and outcomes of Canadian MD/PhD program graduates: a cross-sectional survey

…, DDW Twa, JX Ji, A Kuzyk, X Wang… - … Open Access Journal, 2017 - cmajopen.ca
Background: Combined MD/PhD programs provide a structured path for physician-scientist
training, but assessment of their success within Canada is limited by a lack of quantitative …

[HTML][HTML] Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay

AN Laporte, JX Ji, L Ma, TO Nielsen, BA Brodin - Oncotarget, 2016 - ncbi.nlm.nih.gov
Conventional cytotoxic therapies for synovial sarcoma provide limited benefit. Drugs specifically
targeting the product of its driver translocation are currently unavailable, in part because …

Use of immunohistochemical markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to distinguish endometrial clear cell carcinoma from its morphologic mimics including …

JX Ji, DR Cochrane, B Tessier-Cloutier… - International Journal …, 2020 - journals.lww.com
The diagnosis of clear cell (CC) carcinoma of the endometrium can be challenging, especially
when endometrioid (EC) and serous (SC) endometrial cancers exhibit nonspecific clear …